Hyperfine (NASDAQ:HYPR) Bolsa

Hyperfine

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGMH

ANTE

ARBE

ARLO

ATXI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Las acciones de Harrow subieron un 23,1% en el premercado. Descubre qué otras compañías están ganando y perdiendo antes de la apertura.

Las acciones de Harrow (HROW) se disparan un 23%; aquí están 20 acciones que se mueven en el premercado

Hand,Touching,Brain,And,Network,Connection,On,Glitter,Bright,Lights

Health Care

Tech

General

NVDA

Las acciones de Hyperfine suben tras anunciar su alianza con NVIDIA para integrar IA en su tecnología de resonancia magnética portátil.

Hyperfine (HYPR) y Nvidia (NVDA) se asocian para hacer que las resonancias magnéticas cerebrales sean más asequibles

Hyperfine Inc

HydrogenPro ASA

HYPROP INVESTMENTS by Hyprop Investments Ltd.

Hyprr

On Tuesday, Wedbush Securities analyst Dan Ives said big tech's merger and acquisition activity is ramping up again, following years of regulatory pressure under former Federal Trade Commission Chair Lina Khan.
What Happened: "In our view with Lina Khan gone at the FTC, the M&amp;A engines are back underway in Big Tech after a dark period for tech M&amp;A," Ives wrote on X, formerly Twitter.
"Google kicks off the M&amp;A cycle today with the Wiz deal, which is important for cybersecurity and just the start of a massive consolidation period."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">In our view with Lina Khan gone at the FTC&#8230;the M&amp;A engines are back underway in Big Tech after a dark period for tech M&amp;A. Google kicks off the M&amp;A cycle today with the Wiz deal which is important for cybersecurity and just the start of a massive consolidation period. &#x1f3c6;&#x1f525;&#x1f402;&#x1f37f;
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1901996580841947269?ref_src=twsrc%5Etfw">March 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://in.benzinga.com/analyst-ratings/analyst-color/25/03/44116610/investors-shouldnt-run-to-the-hills-over-tariffs-dan-ives-points-to-8-ai-stocks-to-own">Investors Shouldn&#8217;t &#8216;Run To The Hills&#8217; Over Tariffs: Dan Ives Points To 8 AI Stocks &#8216;To Own&#8217;</a>
Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Google&#8217;s parent company, has reached an <a href="https://in.benzinga.com/news/large-cap/25/03/44386802/googles-wiz-acquisition-strengthens-cybersecurity-suite-adds-to-multicloud-value-proposition-analyst">agreement to acquire cybersecurity</a> startup Wiz for $32 billion in an all-cash transaction.
This landmark deal, aimed at strengthening Google&#8217;s cloud business amid intense competition, marks the company&#8217;s largest acquisition to date and stands as the biggest transaction of 2025 so far.
That same day, Wired <a href="https://www.wired.com/story/federal-trade-commission-removed-blogs-critical-of-ai-amazon-microsoft/">reported</a> that the FTC had removed more than 300 blog posts written during Khan's tenure, including several critical of tech giants like Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) for their data practices.
Why It's Important: The shift in the FTC&#8217;s stance comes amid significant changes in its leadership and approach to tech regulation. President Donald Trump appointed Andrew Ferguson as the new FTC chair in a potential shift toward a <a href="https://www.benzinga.com/markets/24/12/42428224/bitcoin-ethereum-dogecoin-mirror-stock-declines-ahead-of-crucial-inflation-data-release-top-analyst-says-buy-the-dip-predicts-275k-btc-target">less aggressive stance</a> on antitrust enforcement.&nbsp;
Meanwhile, the FTC&#8217;s latest actions, such as the ban on General Motors from <a href="https://www.benzinga.com/25/01/43051842/ftc-bans-general-motors-from-sharing-driver-data-following-allegations-that-it-sold-sensitive-consumer-information">sharing driver data</a> and the lawsuit against PepsiCo for <a href="https://in.benzinga.com/25/01/43063862/whats-going-on-with-pepsico-stock-today">alleged price discrimination</a>, highlight the agency&#8217;s ongoing focus on data privacy and fair competition.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43641265/upstart-q4" target="_blank" rel="noreferrer noopener">Upstart Shares Soar After Solid Q4 Report, Strong Q1 Guidance</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Government

AMZN

GOOG

GOOGL

MSFT

Dan Ives Says Big Tech M&A Is Back 'After A Dark Period' As FTC Wipes Over 300 Lina Khan-Era Blog Posts Criticizing Amazon, Microsoft, And Others

NASA astronauts Sunita Williams and Butch Wilmore have safely returned to Earth after an unexpectedly prolonged mission on the International Space Station (ISS).
The astronauts traveled back in a SpaceX capsule, concluding a mission that was initially scheduled for just over a week but extended to nine months due to complications with their original Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) Starliner spacecraft.
What Happened: Wilmore and Williams, part of NASA&#8217;s Crew-9 rotation, undocked from the ISS at 1:05 a.m. ET and completed a 17-hour journey back to Earth, splashing down safely off Florida&#8217;s Gulf Coast at 5:57 p.m. ET.
Their mission was marked by technical challenges and became a political spectacle, drawing attention from U.S. President Donald Trump, who called for their expedited return.
NASA&#8217;s decision to return Wilmore and Williams on a SpaceX craft was influenced by Trump&#8217;s request, according to NASA&#8217;s ISS chief Joel Montalbano.
See Also:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44299887/tsla-stock-may-see-a-significant-upswing-says-jim-cramer-should-be-ready-to-rally-maybe-furiously"> TSLA Stock May See A Significant Upswing, Says Jim Cramer: &#8216;Should Be Ready To Rally, Maybe Furiously&#8217;</a>
The astronauts will undergo health checks at NASA&#8217;s Johnson Space Center before reuniting with their families. SpaceX CEO Elon Musk supported the earlier return, criticizing the Biden administration&#8217;s handling of the situation.
Wilmore and Williams spent 286 days in space, contributing to 150 science experiments. Williams, on her third spaceflight, has now accumulated 608 days in space, the second most for any U.S. astronaut.
Boeing&#8217;s Starliner may require further uncrewed tests before carrying astronauts regularly, as stated by NASA&#8217;s Commercial Crew Program chief Steve Stich.
Why It Matters: The return of Wilmore and Williams comes after several delays, including a postponed <a href="https://www.benzinga.com/25/03/44296357/spacex-crew-10-astronaut-launch-to-bring-back-stuck-astronauts-delayed-due-to-hydraulics-issue-says-nasa">SpaceX Crew-10 mission</a> due to a hydraulics issue.
This delay was one of the factors prolonging the astronauts&#8217; stay on the ISS. Despite the political undertones suggested by <a href="https://www.benzinga.com/25/03/44161444/starliner-astronaut-butch-wilmore-denies-involvement-of-politics-in-delay-in-returning-home-from-space-refuting-spacex-ceo-elon-musk">Elon Musk</a>, Wilmore emphasized that politics did not play a role in the delay, highlighting the unpredictable nature of human spaceflight.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<a href="https://www.benzinga.com/25/03/44373082/former-nasa-astronaut-predicts-mars-travel-still-15-years-away-not-5-years-as-elon-musk-alludes-to">Former NASA Astronaut Predicts Mars Travel Still 15 Years Away: &#8216;Not 5 Years As Elon Musk Alludes To&#8217;</a>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: NASA

SPACE

Sunita Williams, Butch Wilmore Return To Earth On SpaceX Dragon Capsule After 286 Days In Space, NASA Astronauts To Undergo Health Checks

Fiserv Acquires Netherlands-Based CCV To Fuel European Growth; Deal Terms Not Disclosed

FCPT

Reported Earlier, FCPT Expands Net-Leased Portfolio With $10.1M Sale-Leaseback Deal for Six Burger King Locations

Amid the ongoing opioid crisis, Purdue Pharma has proposed a new bankruptcy plan. The pharmaceutical giant is offering a settlement of at least $7.4 billion to address its role in the crisis.
What Happened: On Tuesday, the OxyContin maker submitted a revised bankruptcy plan, offering a settlement of at least $7.4 billion for the opioid crisis. This decision follows the U.S. Supreme Court&#8217;s rejection of Purdue&#8217;s previous attempt to resolve the lawsuits through a bankruptcy settlement last year.
The new plan provides fresh details on how the settlement will be distributed among states, local governments, and individuals affected by the opioid crisis. The company intends to begin collecting votes and opt-in decisions from its creditors in May, with the plan to be presented to a U.S. bankruptcy judge for final approval upon completion.
Purdue will contribute $900 million from its funds and implement several non-monetary measures, including transitioning into a public benefit company focused on developing medications for opioid use disorder treatment and overdose reversal. 
Under the revised plan, creditors can choose to participate in the settlement to receive payment. Individuals who choose not to participate in the settlement can pursue legal action against the Sacklers, the company&#8217;s owners, who have stated they will strongly contest the case in court.
The revised plan also allocates approximately $850 million to support individuals affected by the opioid crisis, including those who developed addiction after being prescribed OxyContin and infants born with withdrawal symptoms due to prenatal opioid exposure.
SEE ALSO:<a href="https://www.benzinga.com/25/03/44391407/federal-reserve-in-hard-position-with-stagflationary-shock-says-former-treasury-secretary-ahead-of-fomc-decision-this-is-what-tariffs-do"> Larry Summers Says Federal Reserve In Hard Position With &#8216;Stagflationary Shock&#8217; Ahead Of FOMC Decision: &#8216;This Is What Tariffs Do&#8217;</a>
Why It Matters: The opioid crisis, fueled by Purdue Pharma&#8217;s aggressive marketing of OxyContin in the 1990s, has claimed at least 106,000 lives in the U.S. Inappropriate prescribing of opioids was cited as one of the major causes of U.S. overdoses, according to the office of Dept. of Health and Human Services. This settlement, if approved, will conclude the most expensive corporate bankruptcy tied to the opioid epidemic.
The Sackler family and Purdue Pharma previously <a href="https://www.benzinga.com/25/01/43177108/purdue-pharma-sackler-family-to-pay-74-billion-in-settlement-over-oxycontin-that-fueled-devastating-opioid-epidemic">agreed to pay $7.4 billion</a> to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain medication OxyContin accountable for their role in the opioid crisis. &#8220;This story is about a family of cruel billionaires who believed they were above the law,&#8221; said Connecticut Attorney General William Tong in a press release. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/news/global/25/03/44384160/oil-prices-slip-energy-stocks-pause-as-trump-putin-call-signals-ukraine-ceasefire-progress">Oil Prices Slip, Energy Stocks Pause As Trump-Putin Call Signals Ukraine Ceasefire Progress</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Purdue Pharma Says It Will Transform Into 'Public Benefit Company,' As It Files For Bankruptcy — Proposes $7.4 Billion Settlement In Opioid Case

CRWD

Crowdstrike Announced Groundbreaking Agentic Ai Innovations Built On NVIDIA AI Software, Setting A New Standard For AI-powered Cybersecurity

<ul>
<li>Fujitsu and FICO partner to expand FICO&#xAE; Platform's Omni-Channel Engagement Capabilities in Japan from July 2025, with future regional growth</li>
<li>Partnership to enhance financial services with advanced analytics, fraud prevention, and smarter decisioning</li>
<li>Fujitsu will provide end-to-end support, from consulting to system implementation, while FICO delivers technical expertise to meet Japan's evolving financial needs.</li>
</ul>

FICO

FJTSY

Reported Earlier, Fujitsu Joins Forces With FICO To Bring AI-Driven Risk And Engagement Solutions To Japanese Financial Institutions

IVBIY

Reported Earlier, HUTCHMED And Innovent Announce FRUSICA-2 Trial Success As Fruquintinib-Sintilimab Combo Meets Primary Endpoint In Advanced RCC

EPRT

Reported Earlier, Essential Properties Realty Trust Prices $254.2M Upsized Public Offering Of 8.2M Common Stock

Better Home &amp; Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BETR#NASDAQ">BETR</a>) reported $25.00 million in sales this quarter. This is a 38.89 percent increase over sales of $18.00 million the same period last year.

Earnings

BETR

Better Home & Finance Q4 Sales $25.00M Up From $18.00M YoY, Net Loss $206M, Compared To A Loss Of $536M YoY

CFLT

Confluent Announced Significant Advancements In Tableflow, The Easiest Way To Access Operational Data From Data Lakes And Warehouses

Confluent Announced New Capabilities In Confluent Cloud For Apache Flink That Streamline And Simplify The Process Of Developing Real-time Artificial Intelligence Applications

Engineers and researchers throughout Alphabet are working closely with technical teams at NVIDIA to use AI and simulation to develop robots with grasping skills, reimagine drug discovery, optimize energy grids and more. Employing the <a href="https://www.nvidia.com/en-us/omniverse/">NVIDIA Omniverse&#x2122;</a>, <a href="https://www.nvidia.com/en-us/ai/cosmos/">NVIDIA Cosmos&#x2122;</a> and <a href="https://developer.nvidia.com/isaac/">NVIDIA Isaac&#x2122;</a> platforms, teams from Google DeepMind, Isomorphic Labs, Intrinsic and X's moonshot Tapestry will discuss milestones from their respective collaborations at the NVIDIA GTC global AI conference.
To power research and AI production efforts for its customers, Alphabet's Google Cloud will be among the first to adopt the NVIDIA GB300 NVL72 rack-scale solution and NVIDIA RTX PRO&#x2122; 6000 Blackwell Server Edition GPU, also announced today at GTC.

Reported Earlier, NVIDIA And Alphabet Deepen Alliance To Drive The Future Of Agentic AI, Robotics, And Digital Infrastructure

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Extreme Fear&#8221; zone on Tuesday.
U.S. stocks settled lower on Tuesday, with the Nasdaq Composite falling around 300 points during the session. Shares of Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) fell around 4%, while Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) declined more than 3% on Tuesday. The Technology Select Sector SPDR Fund also fell more than 1% during the session.
On the economic data front, U.S. import prices increased by 0.4% in February, versus market estimates of a 0.1% decline. U.S. export prices rose by 0.1% month-over-month in February. U.S. industrial production increased by 0.7% in February, surpassing market estimates of 0.2%.
Most sectors on the S&amp;P 500 closed on a negative note, with communication services, information technology, and consumer discretionary stocks recording the biggest losses on Tuesday. However, energy and healthcare stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 260 points to 41,581.31 on Tuesday. The S&amp;P 500 fell 1.07% to 5,614.66, while the Nasdaq Composite dipped 1.71% to 17,504.12 during Tuesday's session.
Investors are awaiting earnings results from Signet Jewelers Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>), Williams-Sonoma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>), and Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 19.7, the index remained in the &#8220;Extreme Fear&#8221; zone on Tuesday, versus a prior reading of 22.4.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
Photo courtesy: Shutterstock

FIVE

PLTR

Nasdaq Falls 300 Points As Nvidia, Palantir Decline: Greed Index Remains In 'Extreme Fear' Zone

Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/OLLI/earnings">opening bell, on Wednesday, March 19.</a>
Analysts expect the Harrisburg, Pennsylvania-based company to report quarterly earnings at $1.19 per share, down from $1.23 per share in the year-ago period. Ollie&#8217;s Bargain Outlet projects quarterly revenue of $674.52 million, compared to $648.95 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 3, Ollie&#8217;s Bargain Outlet announced the appointment of Eric van der Valk to President &amp; Chief Executive Officer.
Ollie&#8217;s Bargain Outlet shares fell 4.1% to close at $99.06 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>RBC Capital analyst Steven Shemesh maintained an Outperform rating and raised the price target from $130 to $133 on March 7, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Wells Fargo analyst Edward Kelly maintained an Equal-Weight rating and increased the price target from $95 to $105 on Dec. 11, 2024. This analyst has an accuracy rate of 62%.</li>
<li>JP Morgan analyst Matthew Boss maintained an Overweight rating and boosted the price target from $105 to $135 on Dec. 11, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Craig-Hallum analyst Jeremy Hamblin maintained a Buy rating and increased the price target from $107 to $130 on Dec. 11, 2024. This analyst has an accuracy rate of 60%.</li>
<li>Truist Securities analyst Scot Ciccarelli maintained a Buy rating and raised the price target from $109 to $121 on Dec. 11, 2024. This analyst has an accuracy rate of 69%.</li>
</ul>
Considering buying OLLI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="417" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19024916/image-153-1024x417.png" alt="" class="wp-image-830769" style="width:596px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19024916/image-153-1024x417.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19024916/image-153-300x122.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19024916/image-153-768x313.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19024916/image-153.png 1453w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Price Target

Analyst Ratings

OLLI

Top Wall Street Forecasters Revamp Ollie's Bargain Outlet Price Expectations Ahead Of Q4 Earnings

<ul>
<li>This investment will improve the healthcare experience for patients, reinforcing Dassault Systèmes' role in the industry's transformation</li>
<li>Click Therapeutics will gain access to Dassault Systèmes' global presence and expertise to support the development of new therapies</li>
</ul>

DASTY

Dassault Systèmes Deepens Medidata's Reach With Strategic Investment In Click Therapeutics To Advance Digital Patient Care

Will strengthen competitiveness by establishing more autonomous FA systems business in local market

MIELY

Mitsubishi Electric Expands Footprint In China With New FA Systems HQ, Aiming For Agile Localized Operations

Signet Jewelers Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/SIG/earnings">opening bell, on Wednesday, March 19.</a>
Analysts expect the Hamilton, Bermuda-based company to report quarterly earnings at $6.25 per share, down from $6.73 per share in the year-ago period. Signet Jewelers projects quarterly revenue of $2.33 billion, compared to $2.5 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 15, the company said it expects fourth-quarter sales to range between $2.32 billion and $2.335 billion. That's down from the prior forecast of $2.38 billion to $2.46 billion, compared to the $2.45 billion estimate.
Signet Jewelers shares fell 0.1% to close at $48.30 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/sig/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wells Fargo analyst Ike Boruchow maintained an Overweight rating and cut the price target from $110 to $95 on Jan. 15, 2025. This analyst has an accuracy rate of 70%.</li>
<li>B of A Securities analyst Lorraine Hutchinson maintained a Neutral rating and slashed the price target from $95 to $65 on Jan. 15, 2025. This analyst has an accuracy rate of 64%.</li>
</ul>
Considering buying SIG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19023535/image-152-1024x586.png" alt="" class="wp-image-830753" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19023535/image-152-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19023535/image-152-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19023535/image-152-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19023535/image-152.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Signet Jewelers Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Signet Jewelers Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) to report quarterly earnings at $6.25 per share on revenue of $2.33 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Signet shares gained 0.3% to $48.42 in after-hours trading.</li>
<li>Analysts are expecting Williams-Sonoma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) to post quarterly earnings at $2.93 per share on revenue of $2.35 billion. The company will release earnings before the markets open. Williams-Sonoma shares fell 1.6% to close at $172.28 on Tuesday.</li>
<li>HealthEquity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) posted downbeat earnings for its fourth quarter on Tuesday. HealthEquity expects fiscal year 2026 revenue of $1.28 billion to $1.305 billion versus estimates of $1.301 billion. The company anticipates full-year earnings of $3.57 to $3.74 per share versus estimates of $3.71 per share. HealthEquity shares dipped 13.7% to $87.75 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) reported better-than-expected fourth-quarter earnings and sales results. StoneCo shares jumped 10.2% to $10.85 in the after-hours trading session.</li>
<li>Analysts expect Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) to post quarterly earnings at $3.38 per share on revenue of $1.39 billion after the closing bell. Five Below shares rose 1.3% to $74.88 in after-hours trading.</li>
</ul>
Check This Out:<a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
Photo courtesy: Shutterstock

STNE

Williams-Sonoma, HealthEquity And 3 Stocks To Watch Heading Into Wednesday

Former Treasury Secretary Lawrence H. Summers has said that the central bank is facing &#8220;the most difficult challenge&#8221; amid higher prices and fewer jobs. This comes as the Federal Reserve is slated to announce its decision on interest rates by Wednesday afternoon.
What Happened: Larry Summers expects the apex bank&#8217;s monetary policy-setting body, the Federal Reserve Open Market Committee (FOMC), to hold the rates constant on Wednesday in line with market expectations.
CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool </a>indicates a near-certainty of unchanged interest rates in March at 99%, with expectations shifting to significant rate cuts beginning in July with a 60%+ probability and increasing to nearly 90% in September. 
Holding tariffs responsible for this challenging situation, he said, &#8220;This is what tariffs do.&#8221;
&#8220;If you are the Federal Reserve, you can't figure out if you go to the breaks because of price increases or the accelerator because of lost jobs. So I suspect the Fed won't move interest rates. They will say they need more data and they are watching,&#8221; said Summers in an X thread.
He describes this scenario as a &#8220;stagflationary shock,&#8221; which has put the Fed in a &#8220;hard position&#8221;.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The <a href="https://twitter.com/federalreserve?ref_src=twsrc%5Etfw">@federalreserve</a> is in a hard position given this kind of stagflationary shock, I told <a href="https://twitter.com/JohnBerman?ref_src=twsrc%5Etfw">@JohnBerman</a> <a href="https://twitter.com/CNN?ref_src=twsrc%5Etfw">@CNN</a>
&mdash; Lawrence H. Summers (@LHSummers) <a href="https://twitter.com/LHSummers/status/1901998378050859351?ref_src=twsrc%5Etfw">March 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/03/44370387/fed-put-on-standby-while-trump-put-may-be-kaput-analysts-expect-jerome-powell-to-pivot-to-a-measured-stance-amid-economic-uncertainty">Fed Put On Standby, While Trump Put May Be Kaput? Analysts Expect Jerome Powell To Pivot To A Measured Stance Amid Economic Uncertainty </a>
Why It Matters: With inflation near 2% and growing economic uncertainty, analysts believe Jerome Powell might pivot to a more measured approach.
"The hawkish tone of Fed Chair Jerome Powell may likely change into a more measured one as he has to cite the economic uncertainty — especially tariff uncertainty,&#8221; said Eugenia Mykuliak, the founder and executive director at B2PRIME Group
The &#8220;Trump put&#8221; referring to adjusting President Donald Trump-led administration&#8217;s policies to support markets was off the table, the &#8220;Fed put&#8221; remained on standby. "The Trump Put may be kaput, but the Fed Put remains on standby," said Edward Yardeni, the President of Yardeni Research.
Earlier this month, while speaking at the University of Chicago <a href="https://www.benzinga.com/25/03/44213521/us-economic-slowdown-talk-of-the-town-says-economist-mohamed-el-erian-as-fed-chair-powell-reaffirms-growth-at-sol">Powell signaled</a> the Fed will maintain current rates amid a strong labor market and near-target inflation, emphasizing no rush to adjust rates.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Tuesday. The SPY declined 1.08% to $561.02, and the QQQ also dropped 1.70% to $474.54, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Wednesday, the future of Dow Jones rose by 0.13%, whereas the S&amp;P 500 and Nasdaq 100 advanced by 0.19% and 0.26% respectively.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44374442/tesla-investors-advised-to-fasten-their-seatbelts-as-this-analyst-expects-march-deliveries-to-take-a-hit-its-still-best-positioned-company-in-physical-ai">Tesla Investors Advised To Fasten Their Seatbelts As Analyst Expects March Deliveries To Take A Hit: It&#8217;s Still &#8216;Best-Positioned Company In Physical AI&#8217; </a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Economics

Federal Reserve

Larry Summers Says Federal Reserve In Hard Position With 'Stagflationary Shock' Ahead Of FOMC Decision: 'This Is What Tariffs Do'

Press Releases

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Management

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Hyperfine Announces $6.0 Million Registered Direct Offering

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

CTLT

NPCE

NVST

QDEL

Apyx Medical

HeartBeam

CytoSorbents

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Hyperfine

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL